← Back to Influence Map
Entity DossierOrganization
GENENTECH, INC.
CA · US
Leading biotechnology co. focused on medicines for serious or life threatening conditions
Tracked direct giving
$0
LDA reported lobbying spend
$11,290,000
Connections
13
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$19.5MMMMMedicare/Medicaid
$16.8MPHAPharmacy
$16.6MBUDBudget/Appropriations
$16.5MCPTCopyright/Patent/Trademark
$16.1MTRDTrade
$15.9MTAXTaxation/Internal Revenue Code
$15.7MMEDMedical/Disease Research
$14.9MMANManufacturing
$14.9MIMMImmigration
$14.9MLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$14.9M
TODD STRATEGY GROUP$840K
OGR$820K
TARPLIN, DOWNS & YOUNG, LLC$780K
MARSHALL & POPP, LLC$780K
TIBER CREEK HEALTH STRATEGIES, INC.$720K
Harbinger Strategies$720K
AKIN GUMP STRAUSS HAUER & FELD$700K
CORNERSTONE GOVERNMENT AFFAIRS, INC.$700K
King & Spalding LLP$400K
YC CONSULTING, LLC$130K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on PBM Reform Act | Source |
| Retained | TIBER CREEK HEALTH STRATEGIES, INC. | Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on PBM Reform Act | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Retained | OGR | Hired OGR to lobby on PBM Reform Act | Source |
| Retained | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby on Pharmaceuticals | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $3,100,000 | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing Model | Source |
| Retained | AKIN GUMP STRAUSS HAUER & FELD | Hired AKIN GUMP STRAUSS HAUER & FELD to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | Harbinger Strategies | Hired HARBINGER STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | CORNERSTONE GOVERNMENT AFFAIRS, INC. | Hired CORNERSTONE GOVERNMENT AFFAIRS, INC. to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | TODD STRATEGY GROUP | Hired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | King & Spalding LLP | Hired KING & SPALDING LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | YC CONSULTING, LLC | Hired YC CONSULTING, LLC to lobby (4th Quarter (Oct 1 - Dec 31) 2025) | Source |